Clinical Trials Directory

Trials / Completed

CompletedNCT06749379

LIPEDEMA AWARENESS IN FIBROMYALGIA

Status
Completed
Phase
Study type
Observational
Enrollment
100 (actual)
Sponsor
Ufuk University · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

Lipedema is a chronic debilitating condition that impacts the subcutaneous adipose tissue of the extremities. It is a chronic condition but should not be regarded as always progressing.The clinical course varies individually and is unpredictable. It may considerably diminish the patient's quality of life. Fibromyalgia, similar to lipedema, is a debilitating chronic pain disease of unclear origin that primarily affects women. It is a complex syndrome marked by widespread pain and tenderness. Fibromyalgia and lipedema are both marked by pain related to soft tissue. Both disorders are not amenable to curative treatment, resulting in a significant burden on individual and public health. No definitive indicators, including abnormal laboratory or imaging results, can be discerned to differentiate one disorder from another. With this perspective, the aim of our study was to evaluate the presence of lipedema and lipedema-related factors in fibromyalgia patients.

Conditions

Interventions

TypeNameDescription
OTHERPresence and stages of lipedema were diagnosed with examination.Lipedema stage characteristics: stage 1: Smooth skin with a uniform increase in subcutaneous tissue; stage 2: Irregular skin surface with indentations and nodular alterations in the subcutaneous tissue; stage 3: Significant increase in circumference accompanied by loose skin/tissue ('dewlap').

Timeline

Start date
2022-08-01
Primary completion
2023-03-01
Completion
2023-03-01
First posted
2024-12-27
Last updated
2024-12-27

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06749379. Inclusion in this directory is not an endorsement.